Extended Release Tiagabine Formulations with Reduced Side-effects

Details for Australian Patent Application No. 2002325404 (hide)

Owner Abbott Laboratories

Inventors Apfelbaum, Kathleen M; Alvarez, Francisco J; Gustavson, Linda E; Slade, Russell T; Brown, David M

Agent Spruson & Ferguson

Pub. Number AU-B-2002325404

Parent 22395

Filing date 24 December 2002

Wipo publication date 3 April 2003

Acceptance publication date 2 February 2006

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

Event Publications

16 January 2003 Complete Application Filed

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002325404

2 February 2006 Application Accepted

  Published as AU-B-2002325404

1 June 2006 Standard Patent Sealed

14 August 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325405-Composition for the oxidation dyeing of keratin fibres, comprising an oxyalkylenated carboxylic acid ether, a nonionic surfactant and a particular polymer

2002325403-Drive Train Member Having Convex Splines